Register

ABIM Med Oncology Practice Questions - ABIM Medical Oncology Subspecialty Certification Exam

Access More Questions
A 62-year-old woman received neoadjuvant TCHP for clinical T2N1 HER2-positive breast cancer. Surgical pathology shows residual invasive disease in the breast (ypT1cN1). Which adjuvant therapy is most appropriate based on KATHERINE?
Correct Answer:
Trastuzumab emtansine (T-DM1) for 14 cycles

Access more questions from this quiz

Continue to ABIM Med Oncology Practice Questions - ABIM Medical Oncology Subspecialty Certification Exam for more practice questions and the full quiz experience.

Access More Questions